Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% storm

US President Donald Trump's latest tariff announcement has bought India's pharmaceutical industry time, but not certainty.

The US President on Wednesday unveiled a phased tariff plan for imported generic medicines that gives manufacturers a two-year window before imposing sharply higher duties. Under the proposal, generic medicines will continue to enter the US duty-free for two years from August 1, after which imports will attract a 100% tariff for one year before the levy doubles to 200%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.